Literature DB >> 2016764

trans-dominant inhibition of human hepatitis delta virus genome replication.

J S Glenn1, J M White.   

Abstract

Infection with hepatitis delta virus (HDV) is an important cause of acute and chronic liver disease and can be rapidly fatal. Sequencing of the HDV RNA genome has revealed variability at the C-terminal end of the delta antigen reading frame. One genome type (termed the S genome) synthesizes a 24-kDa protein thought to be required for genome replication. Another genome type (termed the L genome) extends the reading frame by 19 amino acids as a result of a single base change. Replication of the S and L genomes was studied in cultured fibroblasts. While the S genome efficiently initiated genome replication, the L genome did not. Moreover, in a codelivery experiment, L genome RNA inhibited replication of the S genome. Potent trans inhibition was also observed following cotransfection of the S genome and a plasmid encoding the larger delta antigen. Mutational analysis indicated that the inhibitory activity was not a simple function of the large delta antigen reading frame's extra length. Implications for the viral life cycle, clinical infection, and potential treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016764      PMCID: PMC240587     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.

Authors:  J W Taylor; J Ott; F Eckstein
Journal:  Nucleic Acids Res       Date:  1985-12-20       Impact factor: 16.971

Review 3.  Functional inactivation of genes by dominant negative mutations.

Authors:  I Herskowitz
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

4.  Antigens of hepatitis delta virus in the liver and serum of humans and animals.

Authors:  K F Bergmann; J L Gerin
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

Review 5.  Rapid evolution of RNA viruses.

Authors:  D A Steinhauer; J J Holland
Journal:  Annu Rev Microbiol       Date:  1987       Impact factor: 15.500

6.  Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication.

Authors:  M Chao; S Y Hsieh; J Taylor
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  The delta agent.

Authors:  M Rizzetto
Journal:  Hepatology       Date:  1983 Sep-Oct       Impact factor: 17.425

8.  Structure, sequence and expression of the hepatitis delta (delta) viral genome.

Authors:  K S Wang; Q L Choo; A J Weiner; J H Ou; R C Najarian; R M Thayer; G T Mullenbach; K J Denniston; J L Gerin; M Houghton
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

9.  Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA.

Authors:  S Makino; M F Chang; C K Shieh; T Kamahora; D M Vannier; S Govindarajan; M M Lai
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

10.  Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope.

Authors:  F Bonino; K H Heermann; M Rizzetto; W H Gerlich
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

View more
  50 in total

1.  Unique properties of the large antigen of hepatitis delta virus.

Authors:  G Moraleda; S Seeholzer; V Bichko; R Dunbrack; J Otto; J Taylor
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

Authors:  L E Modahl; T B Macnaughton; N Zhu; D L Johnson; M M Lai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen.

Authors:  Y P Xia; M M Lai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

6.  By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression.

Authors:  Shuji Sato; Cromwell Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism.

Authors:  J L Casey; K F Bergmann; T L Brown; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  Determination of the multimerization state of the hepatitis delta virus antigens in vivo.

Authors:  Cromwell T Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Ribonucleoprotein complexes of hepatitis delta virus.

Authors:  W S Ryu; H J Netter; M Bayer; J Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication.

Authors:  Dan Cao; Dirk Haussecker; Yong Huang; Mark A Kay
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.